A. Bex

Comparison of the malignant phenotype and genotype of the human androgen-independent cell line DU 145 and a subline derived from metastasis after orthotopic implantation in nude mice.

M. Stöckle, B. Wullich, V. Endris, 2001, Cancer genetics and cytogenetics.

Improved prognosis assessment for patients with bladder carcinoma.

A. Raz, T. Otto, H. Rübben, 1997, The American journal of pathology.

Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions.

H. G. van der Poel, W. Meinhardt, S. Horenblas, 2008, European urology.

LBA4 Adjuvant nivolumab plus ipilimumab (NIVO+IPI) vs placebo (PBO) for localized renal cell carcinoma (RCC) at high risk of relapse after nephrectomy: Results from the randomized, phase III CheckMate 914 trial

R. Motzer, P. Russo, S. Buti, 2022, Annals of Oncology.

LBA66 IMmotion010: Efficacy and safety from the phase III study of atezolizumab (atezo) vs placebo (pbo) as adjuvant therapy in patients with renal cell carcinoma (RCC) at increased risk of recurrence after resection

R. Uzzo, J. Karam, M. Zibelman, 2022, Annals of Oncology.

Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study.

K. Bensalah, N. Rioux-Leclercq, J. Bernhard, 2014, Urologic oncology.